A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
- PMID: 15589308
- DOI: 10.1016/S0140-6736(04)17551-X
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Abstract
Background: Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is commonly misdiagnosed as multiple sclerosis. Neither disease has a distinguishing biomarker, but optimum treatments differ. The relation of neuromyelitis optica to optic-spinal multiple sclerosis in Asia is uncertain. We assessed the capacity of a putative marker for neuromyelitis optica (NMO-IgG) to distinguish neuromyelitis optica and related disorders from multiple sclerosis.
Methods: Indirect immunofluorescence with a composite substrate of mouse tissues identified a distinctive NMO-IgG staining pattern, which we characterised further by dual immunostaining. We tested masked serum samples from 102 North American patients with neuromyelitis optica or with syndromes that suggest high risk of the disorder, and 12 Japanese patients with optic-spinal multiple sclerosis. Control patients had multiple sclerosis, other myelopathies, optic neuropathies, and miscellaneous disorders. We also established clinical diagnoses for 14 patients incidentally shown to have NMO-IgG among 85000 tested for suspected paraneoplastic autoimmunity.
Findings: NMO-IgG outlines CNS microvessels, pia, subpia, and Virchow-Robin space. It partly colocalises with laminin. Sensitivity and specificity were 73% (95% CI 60-86) and 91% (79-100) for neuromyelitis optica and 58% (30-86) and 100% (66-100) for optic-spinal multiple sclerosis. NMO-IgG was detected in half of patients with high-risk syndromes. Of 14 seropositive cases identified incidentally, 12 had neuromyelitis optica or a high-risk syndrome for the disease.
Interpretation: NMO-IgG is a specific marker autoantibody of neuromyelitis optica and binds at or near the blood-brain barrier. It distinguishes neuromyelitis optica from multiple sclerosis. Asian optic-spinal multiple sclerosis seems to be the same as neuromyelitis optica.
Similar articles
-
Revised diagnostic criteria for neuromyelitis optica.Neurology. 2006 May 23;66(10):1485-9. doi: 10.1212/01.wnl.0000216139.44259.74. Neurology. 2006. PMID: 16717206
-
Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.Eur J Neurol. 2009 Mar;16(3):310-6. doi: 10.1111/j.1468-1331.2008.02376.x. Eur J Neurol. 2009. PMID: 19138340
-
Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.Arch Neurol. 2009 Aug;66(8):964-6. doi: 10.1001/archneurol.2009.152. Arch Neurol. 2009. PMID: 19667216 Free PMC article.
-
Neuromyelitis optica.Curr Opin Neurol. 2007 Jun;20(3):255-60. doi: 10.1097/WCO.0b013e32814f1c6b. Curr Opin Neurol. 2007. PMID: 17495617 Review.
-
NMO-IgG: a specific biomarker for neuromyelitis optica.Dis Markers. 2006;22(4):197-206. doi: 10.1155/2006/586306. Dis Markers. 2006. PMID: 17124341 Free PMC article. Review.
Cited by
-
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist.Curr Rheumatol Rep. 2021 Apr 28;23(6):33. doi: 10.1007/s11926-021-01000-2. Curr Rheumatol Rep. 2021. PMID: 33909180 Review.
-
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.Ann N Y Acad Sci. 2016 Feb;1366(1):20-39. doi: 10.1111/nyas.12794. Epub 2015 Jun 10. Ann N Y Acad Sci. 2016. PMID: 26096370 Free PMC article. Review.
-
Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naïve patients with multiple sclerosis.Front Neurol. 2022 Sep 20;13:1012857. doi: 10.3389/fneur.2022.1012857. eCollection 2022. Front Neurol. 2022. PMID: 36203996 Free PMC article.
-
Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases.Front Immunol. 2020 Aug 20;11:1884. doi: 10.3389/fimmu.2020.01884. eCollection 2020. Front Immunol. 2020. PMID: 32973780 Free PMC article. Review.
-
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.Ann Neurol. 2021 May;89(5):895-910. doi: 10.1002/ana.26067. Epub 2021 Mar 30. Ann Neurol. 2021. PMID: 33724534 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical